These results are consistent with the hypothesis that p53-dependent apoptosis of AML cells known to occur with rapid onset (22) is the primary driver of the early response to the calicheamicin/M3814 combination in MV4-11 cells. This evidence concerns the gene TP53 and acute myeloid leukemia.